In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis

The peptide hormone human relaxin-2 (H2-RLX) has emerged as a potential therapy for cardiovascular and fibrotic diseases, but its short in vivo half-life is an obstacle to long-term administration. The discovery of ML290 demonstrated that it is possible to identify small molecule agonists of the cog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: McBride, Andrew, Hoy, Anna M., Bamford, Mark J., Mossakowska, Danuta E., Ruediger, Martin P., Griggs, Jeremy, Desai, Sapna, Simpson, Kate, Caballero-Hernandez, Ivan, Iredale, John P., Pell, Theresa, Aucott, Rebecca L., Holmes, Duncan S., Webster, Scott P., Fallowfield, Jonathan A.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589886/
https://ncbi.nlm.nih.gov/pubmed/28883402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-10521-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados